Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SRV selected as the alliance partner of Senate Properties for the Oulu Main Police Station and Oulu Prison

SRV GROUP PLC     INVESTOR NEWS     04 MARCH 2022    12:00 EET SRV selected as the alliance partner of Senate Properties for the Oulu Main Police Station and Oulu Prison SRV and Senate Properties have signed an agreement for the construction of the Oulu Main Police Station and Oulu Prison. This project will be implemented under a spearhead alliance project model and is valued at about EUR 119 million. The general planning of the project will be completed in the spring. The construction preparation phase will be started immediately. It is intended that if the Government makes a

PUSU x SPINNOVA® ski test results: SPINNOVA® composite challenges glass fibre performance and user experience

ISPO award-winning premium skis from PUSU and Spinnova have performed well with both test skiers and in laboratory tests. New test results reveal that alpine skis strengthened with SPINNOVA® fibre dampen vibrations over 50% faster than traditional glass fibre skis. Spinnova debuted on the composite markets with PUSU in November 2021, and these promising results verified in laboratory testing indicate the potential of SPINNOVA® as high-performance material.New tests conducted at the University of Tampere reinforce the positive feedback that PUSU x SPINNOVA® skis have received from test

Outokumpu’s Annual report 2021 published

Outokumpu OyjStock exchange releaseMarch 4, 2022 at 12.00 noon EETOutokumpu’s Annual report 2021 published Outokumpu has today published the Annual report 2021 in English and Finnish. The Annual report includes Sustainability review, Corporate Governance statement, Remuneration report, Financial statements and Review by the Board of Directors.   Outokumpu publishes the Annual report in English and in Finnish in accordance with European Single Electronic Format (ESEF) reporting requirements with the XHTML format. In line with the ESEF requirements, the reports have been labelled

Indiana Becomes the Newest State on Internet Vikings' U.S. Map

Taking the U.S. by storm, the global iGaming hosting leader, Internet Vikings, has officially announced the start of its operations in the state of Indiana. Steadily expanding across the American iGaming landscape, the company has attained licensing and already established a sound base of customers in a variety of other progressive and well-regulated states. Aiming at the stars and stripes, Internet Vikings is sure to raise the game by supporting all industry-related companies seeking to get their game on in Indiana. Kristoffer Ottosson, the company's Head of Hosting Services, had

Genetic Analysis strengthens its management team by hiring a Head of Operations

OSLO, NORWAY – 4 March 2022: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces today that the Company has strengthened its management team by hiring Mr. Lars Tiller as Head of Operations. Lars Tiller will be responsible for manufacturing and logistics activities in GA.As a result of the increased market demand for the GA-map diagnostic kits, GA has now strengthened its organisation with expertise and know-how from scale-up in the fast-growing diagnostic industry. As Head of Operations, Mr. Lars Tiller will be responsible for manufacturing and logistics and will

Vicore to host R&D Day

Thursday, March 10 at 15-17 CET (9-11 AM EST) Gothenburg, Sweden, March 4, 2022 – Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2 receptor (AT2R), will host a virtual R&D Day with a focus on its primary drug development programs and this new class of medicine, AT2R agonists (ATRAGS), on Thursday, March 10, 2022, from 15:00-17:00 CET/9-11 AM EST.The R&D Day will feature presentations from Key Opinion Leaders (KOL’s) Toby Maher, M.D. Ph.D., from the Keck School of Medicine at the University of

BioStock: Xintela presents the plans for 2022 in its Q4 report

Xintela recently published its fourth quarter report, which describes the company’s plans for 2022. During the year, the stem cell product XSTEM will enter clinical trial for the first time in humans in two different phase I/IIa clinical studies; one in knee osteoarthritis and one in difficult-to-heal leg ulcers, the latter of which will be partly financed by a grant of 4.8 MSEK from Vinnova.Read the full article at biostock.se: https://www.biostock.se/en/2022/03/xintela-presents-the-plans-for-2022-in-its-q4-report/ This is a press release from BioStock - Connecting Innovation &

Members of the board of directors and major shareholders of Veg of Lund intends to exercise warrants of series TO1

Board members and major shareholders in Veg of Lund AB (publ) (“Veg of Lund” or the “Company”) intends to exercise their warrants of series TO1 that were issued during the third quarter of 2021 (“Warrants”). The subscription period for TO1 began 25 February 2022 and runs up to and including 10 March 2022.The holders of warrants have the right for each owned Warrant to subscribe one (1) new share in Veg of Lund to a price of SEK 11.06 per share. The number of warrants of series TO1 that intends to be exercised by members of the board of directors and major shareholders in the Company amounts

New micro-protein helps yeast cells cope with nutrient scarcity

Researchers from the University of Eastern Finland and the University of Montreal (Canada) have discovered that a micro-protein, which they named Nrs1, supports cell division and proliferation when nutrients are scarce. This result, published in PLOS Biology yesterday, sheds a new light on how evolution subtly reshapes the genomes of unicellular microorganisms, providing them with plasticity to adjust their growth and proliferation to ever-changing environments.  At the turn of the millennium, scientists became able to experimentally determine the DNA sequence of entire genomes. They

Successful review of HAMLET Pharma by the EU Horizon 2020 program

Hamlet Pharma has recently delivered its 18-month report to the European Union’s Horizon 2020 program. In their response, the EU states that the project has “fully achieved its objectives and milestones for the period” and “remains in line with the objectives”.The report summarizes the results in four parts. 1. The successful conclusion of the Phase I/II study. The report states that “the results demonstrated good safety and efficacy, which is very encouraging and supports the continued development of Alpha1H towards a Phase III trial”. 2. Transfer of the drug manufacturing

Kemira Oyj: Manager’s transaction; Jukka Hakkila has received Kemira’s shares related to Performance Share Plan

Kemira Oyj, Managers' transactions, March 4, 2022 at 10.05 am (EET)Kemira Oyj: Manager’s transaction; Jukka Hakkila has received Kemira’s shares related to Performance Share Plan  This is the notification according to the EU Market Abuse Regulation that Jukka Hakkila  has received Kemira shares related to the Performance Share Plan. Detailed information about the transaction is given below. Person subject to the notification requirementName: Hakkila, JukkaPosition: Other senior managerIssuer: Kemira OyjLEI: 74370031Y7RK5H88CQ48 Notification type: INITIAL NOTIFICATION

Kemira Oyj: Manager’s transaction; Matthew Pixton has received Kemira’s shares related to Performance Share Plan

Kemira Oyj, Managers' transactions, March 4, 2022 at 10.05 am (EET)Kemira Oyj: Manager’s transaction; Matthew Pixton has received Kemira’s shares related to Performance Share Plan  This is the notification according to the EU Market Abuse Regulation that Matthew Pixton  has received Kemira shares related to the Performance Share Plan. Detailed information about the transaction is given below. Person subject to the notification requirementName: Pixton, MatthewPosition: Other senior managerIssuer: Kemira OyjLEI: 74370031Y7RK5H88CQ48Notification type: INITIAL NOTIFICATION

Kemira Oyj: Manager’s transaction; Esa-Matti Puputti has received Kemira’s shares related to Performance Share Plan

Kemira Oyj, Managers' transactions, March 4, 2022 at 10.05 am (EET)Kemira Oyj: Manager’s transaction; Esa-Matti Puputti has received Kemira’s shares related to Performance Share Plan  This is the notification according to the EU Market Abuse Regulation that Esa-Matti Puputti has received Kemira shares related to the Performance Share Plan. Detailed information about the transaction is given below. Person subject to the notification requirementName: Puputti, Esa-MattiPosition: Other senior managerIssuer: Kemira OyjLEI: 74370031Y7RK5H88CQ48Notification type: INITIAL

Kemira Oyj: Manager’s transaction; Jari Rosendal has received Kemira’s shares related to Performance Share Plan

Kemira Oyj, Managers' transactions, March 4, 2022 at 10.05 am (EET)Kemira Oyj: Manager’s transaction; Jari Rosendal has received Kemira’s shares related to Performance Share Plan  This is the notification according to the EU Market Abuse Regulation that Jari Rosendal  has received Kemira shares related to the Performance Share Plan. Detailed information about the transaction is given below. Person subject to the notification requirementName: Rosendal, JariPosition: Chief Executive OfficerIssuer: Kemira OyjLEI: 74370031Y7RK5H88CQ48 Notification type: INITIAL

Kemira Oyj: Manager’s transaction; Petri Castrén has received Kemira’s shares related to Performance Share Plan

Kemira Oyj, Managers' transactions, March 4, 2022 at 10.05 am (EET)Kemira Oyj: Manager’s transaction; Petri Castrén has received Kemira’s shares related to Performance Share Plan  This is the notification according to the EU Market Abuse Regulation that Petri Castrén  has received Kemira shares related to the Performance Share Plan. Detailed information about the transaction is given below. Person subject to the notification requirementName: Castrén, PetriPosition: Chief Financial OfficerIssuer: Kemira OyjLEI: 74370031Y7RK5H88CQ48Notification type: INITIAL NOTIFICATION

Kemira Oyj: Manager’s transaction; Kim Poulsen has received Kemira’s shares related to Performance Share Plan

Kemira Oyj, Managers' transactions, March 4, 2022 at 10.05 am (EET)Kemira Oyj: Manager’s transaction; Kim Poulsen has received Kemira’s shares related to Performance Share Plan  This is the notification according to the EU Market Abuse Regulation that Kim Poulsen has received Kemira shares related to the Performance Share Plan. Detailed information about the transaction is given below. Person subject to the notification requirementName: Poulsen, KimPosition: Other senior managerIssuer: Kemira OyjLEI: 74370031Y7RK5H88CQ48 Notification type: INITIAL NOTIFICATION

Kemira Oyj: Manager’s transaction; Antti Salminen has received Kemira’s shares related to Performance Share Plan

Kemira Oyj, Managers' transactions, March 4, 2022 at 10.05 am (EET)Kemira Oyj: Manager’s transaction; Antti Salminen has received Kemira’s shares related to Performance Share Plan  This is the notification according to the EU Market Abuse Regulation that Antti Salminen has received Kemira shares related to the Performance Share Plan. Detailed information about the transaction is given below. Person subject to the notification requirementName: Salminen, AnttiPosition: Other senior managerIssuer: Kemira OyjLEI: 74370031Y7RK5H88CQ48 Notification type: INITIAL NOTIFICATION

Kemira Oyj: Manager’s transaction; Eeva Salonen has received Kemira’s shares related to Performance Share Plan

Kemira Oyj, Managers' transactions, March 4, 2022 at 10.05 am (EET)Kemira Oyj: Manager’s transaction; Eeva Salonen has received Kemira’s shares related to Performance Share Plan  This is the notification according to the EU Market Abuse Regulation that Eeva Salonen has received Kemira shares related to the Performance Share Plan. Detailed information about the transaction is given below. Person subject to the notification requirementName: Salonen, EevaPosition: Other senior managerIssuer: Kemira OyjLEI: 74370031Y7RK5H88CQ48 Notification type: INITIAL NOTIFICATION

Kemira Performance Share Plan - directed share issue

Kemira Oyj, Stock Exchange Release, March 4, 2022 at 10.00 am (EET)Kemira Performance Share Plan - directed share issue The Board of Directors of Kemira has on February 10, 2022 decided on a directed share issue related to the reward payment for the shares earned under Kemira’s performance share plan 2019-2023.  In the share issue, 221,128 Kemira shares held by the company have been conveyed on March 4, 2022 without consideration to 76 key employees participating in Kemira’s performance period 2019-2021 in accordance with the terms and conditions of the plan. More detailed information

PLAGAZI AB (PUBL) AND INLANDSBANAN AB SIGNS LETTER OF INTENT FOR DEVELOPMENT OF LOCALLY PRODUCED GREEN HYDROGEN

Plagazi AB (publ) (“Plagazi” or the “Company”) has signed a letter of intent ("LOI") together with Inlandsbanan AB (“IBAB”) with the aim of cooperating on the production and distribution of green hydrogen based on the extraction of hydrogen from non-recyclable waste.Inlandsbanan is a 1000 km long railway that stretches from Gällivare to Mora owned by the Swedish state and was built as a transport link to and from Sweden's most commodity-rich regions with the aim of increasing opportunities for exploitation in northern Sweden. Inlandsbanan is managed by IBAB as infrastructure manager, which

Arto Räty appointed Senior Advisor and leader of New Context group at Miltton

Lieutenant General Arto Räty moves to Miltton as Senior Advisor and leader of the New Context group. Räty has most recently worked as a member of the management team of the energy company Fortum and before that, for example, as Chief of Staff of the Finnish Ministry of Defence, Director of National Defence Courses and Chairman of the Security Committee.Räty has a unique expertise in foreign and security policy, international relations, strategic planning, international crisis management, and business and societal interactions. “The pillars of security in Europe and the international

Teleste Corporation: Managers´ Transactions – Harju

TELESTE CORPORATION   MANAGERS' TRANSACTIONS 4.3.2022 AT 10:00 EET Teleste Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Esa Harju Position: Chief Executive Officer Issuer: Teleste Oyj LEI: 743700CJRQRU0007GN59 Notification type: INITIAL NOTIFICATION Reference number: 10797/4/4 ____________________________________________ Transaction date: 2022-03-03 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009007728 Nature of the transaction: ACQUISITION

BioStock: Cereno Scientific strengthens IPR in Europe

Swedish biotech Cereno Scientific currently has three patent families protecting its lead drug candidate CS1. Combined, the three families cover most major markets around the world. This week, the company has announced being granted a patent belonging to the second patent family in Europe. This means that now two of the three patent families are covering the European market.Read the article at biostock.se: https://www.biostock.se/en/2022/03/cereno-scientific-strengthens-ipr-in-europe/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Inhalation Sciences receives new order worth 23 500 Euro from RISE, the Research Institute of Sweden

(Stockholm, 4 March 2022) Inhalation Sciences (ISAB) has received a new order worth 23 500 Euro from a returning customer – RISE, the Research Institute of Sweden, one of the country’s leading research bodies. RISE is purchasing ISAB’s Nebulizer Aerosol Generator, which enables precise dry powder-like aerosol to be generated from liquid solutions when mounted onto PreciseInhale®. RISE carries out a wide range of international research projects and collaborations, many funded by national and European public bodies.The new order, worth 23 500 Euro, is for ISAB’s Nebulizer Aerosol Generator

There are no items matching the current filter
There are no more items matching the current filter
Back to top